In a still-pregnant patient needing coagulation factor replacement, what risk should be monitored?

• A. Placental abruption
• B. Uteroplacental insufficiency with fetal compromise
• C. Gestational diabetes
• D. Maternal mastitis

Answer: (B)

When a pregnant patient still needs coagulation factor replacement, the focus is on fetal well-being because placental blood flow can be compromised in a coagulopathic state. Uteroplacental insufficiency means the placenta isn’t delivering enough oxygen and nutrients to the fetus, so fetal distress or compromise is a real and immediate concern. Continuous fetal monitoring helps detect nonreassuring patterns (like late decelerations or reduced variability) early, allowing timely intervention to protect the fetus while managing the mother’s coagulation needs.

Gestational diabetes and maternal mastitis aren’t directly linked to the need for coagulation factor replacement or to acute fetal distress in this context. Placental abruption is a related risk in coagulopathy scenarios, but the key risk to monitor for the fetus here is uteroplacental insufficiency with fetal compromise.